Sickle cell has been overlooked for far too long. Fortunately, there are new breakthroughs in sickle cell treatment that you ...

Data on the first two patients to be treated with a CRISPR-based drug for the blood disorders beta thalassaemia and sickle cell disease suggest they can reduce symptoms. The closely-watched trial ...

In December 2020, the New England Journal of Medicine published a paper titled CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia, marking an exciting new chapter in the treatment of ...